{"SPADE_UN_16478": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16478", "Peptide Name": "BimEL-I146Y", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LRPEIRYAQELRRIGDEFNE", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Bcl-2/Bcl-xL", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C109H174N34O34", "Mass": 2504.76, "PI": 5.16, "Net Charge": -1, "Hydrophobicity": -1.23, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2", "Pubmed ID": "30860026", "Reference": "Elife. 2019 Mar 12;8e37689.", "Author": "Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30860026"}], "Frequent Amino Acids": "ERI", "Absent Amino Acids": "CHKMOSTUVW", "Basic Residues": 4, "Acidic Residues": 5, "Hydrophobic Residues": 8, "Polar Residues": 8, "Positive Residues": 4, "Negative Residues": 5, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16482", "Similarity": 0.95, "Sequence": "LRPEIRYARELRRIGDEFNE"}, {"SPADE_ID": "SPADE_UN_16483", "Similarity": 0.95, "Sequence": "LRPEIRYAQELRRMGDEFNE"}, {"SPADE_ID": "SPADE_UN_16494", "Similarity": 0.9166666666666666, "Sequence": "IAQELRRIGDEF"}]}}}